Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury

NCT: NCT07264868 · RECRUITING

NCT IDNCT07264868
StatusRECRUITING
Start Date2026-05-07
Completion2028-09-01

Brief Summary

The purpose of this study is to determine the safety and efficacy of Injectrode Tibial Nerve Stimulation for bladder function in people with spinal cord injury.

Frequently Asked Questions

What is Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury?

Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury is a clinical trial registered under NCT07264868. Current status: RECRUITING.

What is the status of NCT07264868?

The current status of NCT07264868 (Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury) is: RECRUITING.

When did Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury start?

Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury started on 2026-05-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑